Vaillant Justiz,Goyal AA,Varacallo A,M A,Island (FL): StatPearls Publishing A . .. Systemic Lupus Erythematosus. [Updated 2023 Aug, 4 : .
Drosos GC,Vedder D,Houben E,Boekel L,Atzeni F,Badreh S .2022 .EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome. Ann Rheum Dis, 10(6) : 221733-79.
Vavlukis M,Pop-Gjorcevab D,Poposka L,Sandevska E,Kedev S. Myocardial .2021 .Infarction in Systemic Lupus Erythematosus-the Sex-Specific Risk Profile. Curr Pharm Des, 10(29) : 3221-8.
Semalulu T,Tago A,Zhao K,Tselios K. Managing Cardiovascular K .2023 .Risk in Systemic Lupus Erythematosus: Considerations for the Clinician. Immunotargets Ther, 10 : 175-86.
Garg S,Bartels CM,Bao G,Helmick CG,Drenkard C,Lim SS .2023 .Timing and Predictors of Incident Cardiovascular Disease in Systemic Lupus Erythematosus: Risk Occurs Early and Highlights Racial Disparities. J Rheumatol, 10(1) : 84-92.
Kostopoulou M,Nikolopoulos D,Parodis I,Bertsias G .2020 .Cardiovascular Disease in Systemic Lupus Erythematosus: Recent Data on Epidemiology, Risk Factors and Prevention. Curr Vasc Pharmacol, 10(6) : 549-65.
Bello N,Meyers KJ,Workman J,Hartley L,McMahon M .2023 .Cardiovascular events and risk in patients with systemic lupus erythematosus: Systematic literature review and meta-analysis. Lupus, 10(3) : 325-41.
Jha SB,Rivera AP,Monar GV,Islam H,Puttagunta SM,Islam R .2022 .Systemic lupus erythematosus and cardiovascular disease. Cureus, 10(2) : .
Li D,Yoshida K,Feldman CH,Speyer C,Barbhaiya M,Guan H .2020 .Initial disease severity, cardiovascular events and all-cause mortality among patients with systemic lupus erythematosus. Rheumatology (Oxford), 10(3) : 495-504.
Gullo AL,Rodríguez-Carrio J,Gallizzi R,Imbalzano E,Squadrito G,Mandraffino G .2020 .Speckle tracking echocardiography as a new diagnostic tool for an assessment of cardiovascular disease in rheumatic patients. Prog Cardiovasc Dis, 03(3) : 327-40.
Zoccali C,Mark PB,Sarafidis P,Agarwal R,Adamczak M,Bueno de Oliveira R M .2023 .Diagnosis of cardiovascular disease in patients with chronic kidney disease. Nat Rev Nephrol, 10(11) : 4-46.
Barber MR,Drenkard C,Falasinnu T,Hoi A,Mak A,Kow NY .2021 .Global epidemiology of systemic lupus erythematosus. Nat Rev Rheumatol, 10(9) : 1-32.
Aringer M,Johnson SR .2021 .Systemic lupus erythematosus classification and diagnosis. Rheum Dis Clin North Am, 04(3) : 501-11.
Johnson SR,Gladman DD,Brunner HI,Isenberg D,Clarke AE,Barber MR .2023 .Evaluating the construct of damage in systemic lupus erythematosus. Arthritis Care Res (Hoboken), 10(5) : 998-1006.
Popescu BA,Stefanidis A,Fox KF,Cosyns B,Delgado V,Di Salvo V .2020 .Training, competence, and quality improvement in echocardiography: the European Association of Cardiovascular Imaging Recommendations: update 2020. Eur Heart J Cardiovasc Imaging, 10(12) : 1305-19.
Zhao LL,Takeuchi T,Avihingsanon Y,Yu XQ,Lapid EA,Lugue-Lizardo LR .2013 .Overview of Lupus Nephritis Management Guidelines and Perspective from Asia. Int J Rheum Dis, 10(6) : 12212-185X.
Zhang H,Yang C,Gao F,Hu S,Ma H .2022 .Evaluation of left ventricular systolic function in patients with systemic lupus erythematosus using ultrasonic layer-specific strain technology and its association with cardiovascular events: a long-term follow-up study. Cardiovasc Ultrasound, 10 : 25.
Diaz‐Gallo LM,Oke V,Lundström E,Elvin K,Ling Wu Y,Eketjäll S .2022 .Four systemic lupus erythematosus subgroups, defined by autoantibodies status, differ regarding HLA‐DRB1 genotype associations and immunological and clinical manifestations. ACR Open Rheumatol, 10(1) : 27-39.
Dabit JY,Valenzuela-Almada MO,Vallejo-Ramos S,Duarte-García A .2021 .Epidemiology of antiphospholipid syndrome in the general population. Curr Rheumatol Rep, 10(12) : 85.
Leone P,Cicco S,Prete M,Solimando AG,Susca N,Crudele L .2020 .Early echocardiographic detection of left ventricular diastolic dysfunction in patients with systemic lupus erythematosus asymptomatic for cardiovascular disease. Clin Exp Med, 10(1) : 8-19.
Gegenava T,Gegenava M,Steup-Beekman GM,Huizinga TW,Bax JJ,Delgado V .2020 .Left ventricular systolic function in patients with systemic lupus erythematosus and its association with cardiovascular events. J Am Soc Echocardiogr, 04(9) : 1116-22.
Hussain K,Gauto-Mariotti E,Cattoni HM,Arif AW,Richardson C,Manadan A .2021 .A meta-analysis and systematic review of valvular heart disease in systemic lupus erythematosus and its association with antiphospholipid antibodies. J Clin Rheumatol, 10(8) : e525-32.
Ming Wang TK,Chan N,Khayata M.,Cardiovascular Manifestations M. .2022 .Outcomes in Systemic Lupus Erythematosus: An Eight-Year Single Center Experience in the United States. Angiology, 10 : 877-86.
Venturelli V,Abrantes AM,Rahman A,Isenberg DA .2024 .The impact of antiphospholipid antibodies/ antiphospholipid syndrome on systemic lupus erythematosus. Rheumatology (Oxford), 10 : SI72-85.
Liang H,Ma C,Chen X .2022 .Case report: Mitral valve replacement for Libman-Sacks endocarditis and cerebral embolism of primary antiphospholipid syndrome. Front Cardiovasc Med, 985111 : 985111.
Attuquayefio S,Doku A,Dey D,Agyekum F,Akumiah FK,Kweki AG .2023 .Cardiac Abnormalities in Relation to the Disease Activity Index Among Systemic Lupus Erythematosus Patients in a Tertiary Hospital: A Cross-Sectional Study. Cureus, 10(11) : .
Abdelrahman W,Sakr SA,Gohar N. .2022 .Impact of antiphospholipid syndrome on disease characteristics and outcome in patients with systemic lupus erythematosus. Egypt Rheumatol, 11 : 67-72.
Sevim E,Zisa D,Andrade D,Sciascia S,Pengo V,Tektonidou MG .2022 .Characteristics of patients with antiphospholipid antibody positivity in the APS ACTION International Clinical Database and Repository. Arthritis Care Res (Hoboken), 10(2) : 324-35.